Seminars & Events

Upcoming Events

Path to Program Project Grant Webinars

NSI funded two projects in December 2019 through its Path to Program Project Seed Grant Program. These projects had high potential to lead to program project or center style grants, which require significant resources and investigator collaboration. 

We invite all to attend our upcoming Path to Program Project Grant Webinars and hear about the progress the teams have made. Download a flyer, and see more information below.

Thursday, May 27 / 1:00 - 2:00 PM: Norman Foster, MD, "Utah Exploratory Alzheimer's Disease Research Center" 

Wednesday, June 23 / 1:00 - 2:00 PM: Monica Vetter, PhD, "Translational Strategies for Neuroprotection in a New Model of Open Angle Glaucoma" 

  • $100,000 seed grant, targeting an R24 NEI Translational Research Program Grant. Promising initial data show that a TRPV4 antagonist developed at the U of Utah reversibly reduces inerocular pressure to control levels in mice with experimentally induced ocular hypertension. 

Neurology Grand Rounds

June 2, 9:00 - 10:00 AM: Sonesh Amin & Dan Nguyen (Residents)
June 9, 9:00 - 10:00 AM: Paolo Moretti
June 16, 9:00 - 10:00 AM: Cancelled due to Baringer Symposium (Resident Graduation)
June 23, 9:00 - 10:00 AM: Kelsey Barrell
June 30, 9:00 - 10:00 AM: Anish Deshmukh & Liam Clark (Residents)

Please use this Zoom link for all Grand Round dates listed above: https://utah-health.zoom.us/j/97166613524?pwd=V3lEclRjd3FPeXhRK2QzRzJ0ZTAvQT09
Meeting ID: 971 6661 3524    /    Passcode: Neuro

Join by Skype for Business: https://utah-health.zoom.us/skype/97166613524

New Gila Journal Lab

The Wilcox Lab is excited to announce the formation of a Glia Journal Club. The goal of this group is to stay up to date on the roles of glial cells in health and disease through recent publication and research-in-progress discussions.

Note: Paper and research need not be only glia-related. Immune, vascular, mural cell interactions in CNS and PNS health and disease, as well as any number of topics are also welcome for discussion.

Our first meeting will be July 30th at 3:00 PM via Zoom and continue monthly on the last Friday of each month. The format will aim for a 30-40 minute presentation of a recent publication or research project, followed by discussion. We’ll start off virtual, but perhaps shift to an in-person meeting towards the fall.

Please use this form to sign up if you are interested in participating or attending: https://forms.gle/Yy9pxHGvXj3xuPcK6

Additional Events

EEG Teaching Conference
June 17 @ 12:00 pm - 1:00 pm Join Zoom Meeting
https://utah-health.zoom.us/j/93705849421?pwd=YkU3OWtaeC84L0JLOWlWSlo3VWRzdz09
Meeting ID: 937 0584 9421 / Passcode: 397288

EEG Teaching Conference
June 24 @ 12:00 pm - 1:00 pm Join Zoom Meeting
https://utah-health.zoom.us/j/93705849421?pwd=YkU3OWtaeC84L0JLOWlWSlo3VWRzdz09
Meeting ID: 937 0584 9421 / Passcode: 397288
 
Practical Neurology Sessions
June 17 @ 6:00 pm - 7:30 pm
https://utah-health.zoom.us/j/93934146376?pwd=L3V6clZ0S1FHTjhwbm95NmdRdkhvZz09

Previous Events

Neurodegeneration Symposium - Fall 2020

Neurodegenerative processes are an extrodinarily widespread phenomenon found in a range of neurologic, psychiatric and neurobehavioral disorders. While the mechanisms underlying neurodegeneration are considered multifactorial, characterization of neuronal loss at the cellular and circuit level have the potential to provide important insights into disease pathology and progression resulting in potential novel therapeutic approaches. Brain diseases with neurodegeneration have often identified atypical neuroinflammatory processes, impaired bioenergetics and abnormal protein aggregation as potential mechanisms. Using advanced PET and magnetic resonance imaging approaches and genetic methods the symposium speakers presented important new findings describing brain cell structures, neurochemistry and brain function.

The event was superbly summarized by Dr. Satoshi Minoshima, the Symposium Chair, who concluded  “The field of neurodegeneration has advanced greatly in the past 30 years. Presently multilevel approaches across genetics, physiology, biomarker imaging, and biochemistry are offering increased understanding of the effects of neurodegeneration not only on neurons but also associated components such as astrocytes, the blood brain barrier, and molecular stasis. Together these approaches are allowing for novel therapeutics in a burgeoning and interesting subdiscipline within neuroscience." 

Alexander Drzezga, M.D.
Professor and Chair in Nuclear Medicine
Department of Nuclear Medicine, University Hospital of Cologne
"Multimodal Molecular Imaging of Dementia"
 
Ryan Watts, Ph.D.
Chief Executive Officer, Denali Therapeutics
"Engineering Brain Delivery to Treat Neurodegeneration"
 
Paul S. Bernstein, M.D., Ph.D.
Val A. and Edith D. Green Presidential Professor of Ophthalmology & Visual Sciences
Moran Eye Center, University of Utah
"Macular Telangiectasia Type 2: Reuniting an Orphan Retinal Disease with its Genetic and Neurologic Heritage"

Donna J. Cross, Ph.D.
Associate Professor, Neuroimaging and Biotechnology Lab
Department of Radiology & Imaging Sciences, University of Utah
"Imaging for Research of Neurodegeneration and CNS Injury"
 
Satoshi Minoshima, M.D., Ph.D.
Professor and Chair, Department of Radiology & Imaging Sciences
University of Utah
Closing Remarks

We're thankful to all who participated in the Neurodegeneration Symposium on September 23. If you missed the talks by Dr. Paul Bernstein and Dr. Donna J. Cross, you can watch them here.

How Artificial Intelligence Will Change Psychiatry & Mental Health Research

Christopher Gregg, Associate Professor in Neurobiology & Anatomy, gave the following seminar at the February 2020 Psychiatry Grand Rounds. This is a great example of how U of Utah Neuroscience researchers are thinking about addressing the major issues related to Mental Health.

Neurobiology of Suicide Symposium

In collaboration with the Department of Psychiatry the Neuroscience Initiative hosted the Neurobiology of Suicide Symposium in November 2019.  The symposium was attended by over 100 people from an array of backgrounds including healthcare workers, research scientists, school councilors, community outreach organizers, postdoctoral fellows, graduate & undergraduate students.  Presentations focused on the cellular, neural circuit, neurochemistry, and environmental factors that influence suicidal behavior & ideation.  The evening concluded with a thought provoking panel discussion that demonstrated the breadth and importance of the research area.  Video of the presentations is available below:

Neuroscience Initiative Seed Grant Symposium - Spring 2019

We are hosting the Annual Neuroscience Initiative Seed Grant Symposium on Tuesday May 07, 2019 in the Clinical Neuroscience Center Auditorium. This event includes 5 invited talks from 2018-2019 Neuroscience Initiative Seed Grant awardees and their research teams. The guest speakers will be sharing their exciting cutting edge research work and this event presents an excellent opportunity to network and collaborate!

Events Calendar

Upcoming Events

View Calendar

Director

Deborah Yurgelun-Todd, PhD
Professor, Department of Psychiatry
Director, Neuroscience Initiative

Contact Us
Neuroscience Initiative
383 Colorow, Room 307
Salt Lake City, UT 84108

Sean Flynn, PhD
Associate Director, Neuroscience Initiative
Email: sean.flynn@hsc.utah.edu